Advertisement

Gwalior: 55-year-old woman gets wrong vaccine dose, probe ordered

08:38 PM Aug 01, 2021 | FP News Service

Gwalior (Madhya Pradesh): In a case of gross medical negligence, a 55-year-old, who had received Covishield as her first dose of vaccination against Covid-19, was allegedly administered Covaxin as her second dose in Gwalior on Sunday.

According to information Poonam Devi Chouhan, a resident of Gospura, had received Covishield as her first dose of vaccine on April 11. She was administered the first dose of Covaxin in place of the second dose of Covishiled at Hajira Hospital on Sunday.

Advertisement
Advertisement

When she reached the hospital, she was given a slip and asked to go to the vaccination room, where she was administered the first dose of Covaxin in place of the second dose of Covishield.

Advertisement

The negligence came to light when Poonam reached back home and his son checked the message in her mobile phone.

Hearing that she was given the wrong dose of vaccine, she fell unconscious. She was taken to Hajira hospital. The family members claimed there was no doctor to attend the patient. Subsequently, family members created ruckus.

“I showed my Adhar card and also the message of the first dose. But, they gave me a slip and asked to go to the vaccination room,” Poonam told journalists.

Later, a police team and health department officials rushed the spot and persuaded the family members.

Vaccination officer, Dr RK Gupta said that a probe had been ordered into the matter. “If she has been given the first dose of Covaxin, she may now take the second dose after 28 days. She wouldn’t have any medical complications," he said.

Gwalior: Police Sama App urges quarrelling neighbours to dismantle wall, live in piece

(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

(To view our epaper please Read Now. For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Advertisement